ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda and Frazier Healthcare Partners collaborate to develop clinical-stage norovirus vaccine candidate
August 03, 2021Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners have collaborated to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialise Takeda’s norovirus vaccine candidate. -
Takeda and Frazier to launch HilleVax for norovirus vaccine development
August 02, 2021Takeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previously TAK-214).
Pharma Sources Insight January 2025
